Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 23 - 28 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.22303 İndeks Tarihi: 24-05-2023

A New Target in Inflammatory Diseases: Lycopene

Öz:
Inflammation is a response to various injuries, illnesses, and severe trauma. The primary function of inflammation is to combat pathogens, eliminate them from the body, and initiate wound healing. However, inflammation also contributes to numerous diseases, such as cancer, cardiovascular disease, diabetes, obesity, osteoporosis, rheumatoid arthritis, inflammatory bowel disease, and asthma. As the importance of nutrition in maintaining human health has become increasingly recognized, the consumption of natural antioxidants has gained popularity, especially in developed countries. A growing body of research has shown that consuming foods rich in lycopene can protect individuals from a range of conditions, including cancer, heart disease, and other diseases. As a result, lycopene is gaining recognition as a potential protective antioxidant in the fields of medicine and pharmacology. This review aims to highlight the effects of lycopene on inflammatory diseases and provide a foundational understanding for researchers interested in further research on lycopene.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Chen L, Deng H, Cui H, et al. Inflammatory responses and infla mmati on-as socia ted diseases in organs. Oncotarget. 2018;9(6):7204-7218. [CrossRef]
  • 2. Calder PC, Ahluwalia N, Albers R, et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr. 2013;109(suppl 1):S1-S34. [CrossRef]
  • 3. Laveti D, Kumar M, Hemalatha R, et al. Antiinflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets. 2013;12(5):349-361. [CrossRef]
  • 4. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398-406. [CrossRef]
  • 5. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27-37. [CrossRef]
  • 6. Palozza P, Parrone N, Catalano A, Simone R. Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem. 2010;17(23):2547-2563. [CrossRef]
  • 7. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491. [CrossRef]
  • 8. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117(4):1162-1172. [CrossRef]
  • 9. Polat G, Ugan RA, Cadirci E, Halici Z. Sepsis and septic shock: current treatment strategies and new approaches. Eurasian J Med. 2017;49(1):53- 58. [CrossRef]
  • 10. Reis Machado J, Soave DF, da Silva MV, et al. Neonatal sepsis and inflammatory mediators. Mediators Inflamm. 2014;2014:1-10. [CrossRef]
  • 11. Lawrence T. The nuclear factor NF−κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651-a001651. [CrossRef]
  • 12. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. [CrossRef]
  • 13. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. [CrossRef]
  • 14. Huang MT, Ghai G, Ho CT. Inflammatory process and molecular targets for antiinflammatory nutraceuticals. Compr Rev Food Sci Food Saf. 2004;3(4):127-139. [CrossRef]
  • 15. Caseiro M, Ascenso A, Costa A, Creagh-Flynn J, Johnson M, Simões S. Lycopene in human health. LWT. 2020;127:109323. [CrossRef]
  • 16. Mirahmadi M, Azimi-Hashemi S, Saburi E, Kamali H, Pishbin M, Hadizadeh F. Potential inhibitory effect of lycopene on prostate cancer. Biomed Pharmacother. 2020;129:110459. [CrossRef]
  • 17. Feng D, Ling WH, Duan RD. Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-κB in macrophages. Inflamm Res. 2010;59(2):115-121. [CrossRef]
  • 18. Gegin S, Celikel S, Celik D, Pazarli AC. Evaluation of interleukin-6, leukotriene B-4, and nitric oxide levels in exhaled breath condensate of asymptomatic obese individuals: are obese patients under risk of developing asthma? Eurasian J Med. 2020;52(1):25-28. [CrossRef]
  • 19. Celik H, Kucukler S, Ozdemir S, et al. Lycopene protects against central and peripheral neuropathy by inhibiting oxaliplatin-induced ATF-6 pathway, apoptosis, inflammation and oxidative stress in brains and sciatic tissues of rats. Neurotoxicology. 2020;80:29-40. [CrossRef]
  • 20. Khoo HE, Prasad KN, Kong KW, Jiang Y, Ismail A. Carotenoids and their isomers: color pigments in fruits and vegetables. Molecules. 2011;16(2):1710-1738. [CrossRef]
  • 21. van Steenwijk HP, Bast A, de Boer A. The role of circulating lycopene in low-grade chronic inflammation: a systematic review of the literature. Molecules. 2020;25(19):4378. [CrossRef]
  • 22. Magne TM, da Silva de Barros AO, de Almeida Fechine PB, Alencar LMR, Ricci-Junior E, Santos- Oliveira R. Lycopene as a multifunctional platform for the treatment of cancer and inflammation. Rev Bras Farmacogn. 2022;32(3):321-330. [CrossRef]
  • 23. Buyuklu M, Kandemir FM, Ozkaraca M, et al. Beneficial effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney. Hum Exp Toxicol. 2015;34(5):487-496. [CrossRef]
  • 24. Bin-Jumah MN, Nadeem MS, Gilani SJ, et al. Lycopene: a natural arsenal in the war against oxidative stress and cardiovascular diseases. Antioxidants (Basel). 2022;11(2):232. [CrossRef]
  • 25. Kelkel M, Schumacher M, Dicato M, Diederich M. Antioxidant and anti-proliferative properties of lycopene. Free Radic Res. 2011;45(8):925-940. [CrossRef]
  • 26. Obermüller-Jevic UC, Olano-Martin E, Corbacho AM, et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr. 2003;133(11):3356-3360. [CrossRef]
  • 27. Ono M, Takeshima M, Nakano S. Mechanism of the anticancer effect of lycopene (tetraterpenoids). Enzymes. 2015:139-166. [CrossRef]
  • 28. Khan UM, Sevindik M, Zarrabi A, et al. Lycopene: food sources, biological activities, and human health benefits. Oxid Med Cell Longev Konsue N, et al., ed. 2021;2021:2713511. [CrossRef]
  • 29. Laranjeira T, Costa A, Faria-Silva C, et al. Sustainable valorization of tomato by-products to obtain bioactive compounds: their potential in inflammation and cancer management. Molecules. 2022;27(5):1701. [CrossRef]
  • 30. Aydin S, Palabiyik SS, Erkekoglu P, Sahin G, Başaran N, Giray BK. The carotenoid lycopene protects rats against DNA damage induced by ochratoxin A. Toxicon. 2013;73:96-103. [CrossRef]
  • 31. Przybylska S, Tokarczyk G. Lycopene in the prevention of cardiovascular diseases. Int J Mol Sci. 2022;23(4):1957. [CrossRef]
  • 32. Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol. 2014;26(1):64- 71. [CrossRef]
  • 33. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009;27(1):165-197. [CrossRef]
  • 34. Bathoorn E. Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:217-229. [CrossRef]
  • 35. Zhang X, Liu X, Guo Y, Wu F. Strategies for visualizing inflammation. View. 2021;2(1):20200025. [CrossRef]
  • 36. Veauthier B, Hornecker JR. Crohn’s disease: diagnosis and management. Am Fam Phys. 2018;98(11):661-669.
  • 37. Odabasoglu F, Halici Z, Cakir A, et al. Beneficial effects of vegetable oils (corn, olive and sunflower oils) and α-tocopherol on anti-inflammatory and gastrointestinal profiles of indomethacin in rats. Eur J Pharmacol. 2008;591(1-3):300-306. [CrossRef]
  • 38. Cadirci E, Altunkaynak BZ, Halici Z, et al. Alphalipoic acid as a potentıal target for the treatment of lung ınjury caused by cecal ligation and puncture- induced sepsis model in rats. Shock. 2010;33(5):479-484. [CrossRef]
  • 39. Yıldız MO, Çelik H, Caglayan C, Genç A, Doğan T, Satıcı E. Neuroprotective effects of carvacrol against cadmium-induced neurotoxicity in rats: role of oxidative stress, inflammation and apoptosis. Metab Brain Dis. 2022;37(4):1259- 1269. [CrossRef]
  • 40. Polat B, Halici Z, Cadirci E, et al. The effect of alpha-lipoic acid in ovariectomy and infla mmati on-me diate d osteoporosis on the skeletal status of rat bone. Eur J Pharmacol. 2013;718(1-3):469- 474. [CrossRef]
  • 41. Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol. 2013;4:263. [CrossRef]
  • 42. Verma AK, Aggarwal A, Kumar K. Oxıdatıve stress in chronic obstructıve pulmonary disease and effect of lycopene (a dietary supplement) on markers of oxidative stress, inflammation & pulmonary function. J Evol Med Dent Sci. 2013;2(38):7317-7323. [CrossRef]
  • 43. Lee CM, Chang JH, Moon DO, et al. Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma. Biochem Biophys Res Commun. 2008;374(2):248-252. [CrossRef]
  • 44. Campos KKD, Araújo GR, Martins TL, et al. The antioxidant and anti-inflammatory properties of lycopene in mice lungs exposed to cigarette smoke. J Nutr Biochem. 2017;48:9-20. [CrossRef]
  • 45. Renju GL, Muraleedhara Kurup G, Saritha Kumari CH. Anti-inflammatory activity of lycopene isolated from Chlorella marina on type II collagen induced arthritis in Sprague Dawley rats. Immunopharmacol Immunotoxicol. 2013;35(2):282-291. [CrossRef]
  • 46. Kalpakcioglu B, Şenel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. 2008;27(2):141-145. [CrossRef]
  • 47. Moia VM, Leal Portilho F, Almeida Pádua T, et al. Lycopene used as anti-inflammatory nanodrug for the treatment of rheumatoid arthritis: animal assay, pharmacokinetics, ABC transporter and tissue deposition. Colloids Surf B Biointerfaces. 2020;188:110814. [CrossRef]
  • 48. Ünlü Y, Karapolat S, Karaca Y, Kızıltunç A. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease. Thromb Res. 2006;117(4):357-364. [CrossRef]
  • 49. Arı E, Kaya Y, Demir H, et al. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients. Hemodial Int. 2011;15(4):453-459. [CrossRef]
  • 50. Aksakal E, Akaras N, Tanboga IH, et al. Relationship between oxidative stress and cardiomyopathic changes in ovariectomized rats. Cardiology. 2011;119(4):235-241. [CrossRef]
  • 51. Cinar I, Yayla M, Tavaci T, et al. In vivo and in vitro cardioprotective effect of gossypin against isopr otere nol-i nduce d myocardial infarction injury. Cardiovasc Toxicol. 2022;22(1):52-62. [CrossRef]
  • 52. Mozos I, Stoian D, Caraba A, Malainer C, Horbańczuk JO, Atanasov AG. Lycopene and vascular health. Front Pharmacol. 2018;9:521. [CrossRef]
  • 53. He Y, Xia P, Jin H, Zhang Y, Chen B, Xu Z. Lycopene ameliorates transplant arteriosclerosis in vascular allograft transplantation by regulating the NO/cGMP pathways and rho-associated kinases expression. Oxid Med Cell Longev. 2016;2016:3128280. [CrossRef]
  • 54. Palozza P, Simone R, Catalano A, et al. Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression. J Nutr Biochem. 2011;22(3):259-268. [CrossRef]
  • 55. Kılıç Y, Geyikoglu F, Çolak S, Turkez H, Bakır M, Hsseinigouzdagani M. Carvacrol modulates oxidative stress and decreases cell injury in pancreas of rats with acute pancreatitis. Cytotechnology. 2016;68(4):1243-1256. [CrossRef]
  • 56. Bakır M, Geyikoglu F, Colak S, Turkez H, Bakır TO, Hosseinigouzdagani M. The carvacrol ameliorates acute pancreatitis-induced liver injury via antioxidant response. Cytotechnology. 2016;68(4):1131-1146. [CrossRef]
  • 57. Choi S, Kim H. The remedial potential of lycopene in pancreatitis through regulation of autophagy. Int J Mol Sci. 2020;21(16):5775. [CrossRef]
  • 58. Kang M, Park KS, Seo JY, Kim H. Lycopene inhibits IL-6 expression in cerulein-stimulated pancreatic acinar cells. Genes Nutr. 2011;6(2):117-123. [CrossRef]
  • 59. Özkan E, Akyüz C, Dulundu E, et al. Protective effects of lycopene on cerulein-induced experimental acute pancreatitis in rats. J Surg Res. 2012;176(1):232-238. [CrossRef]
  • 60. M’Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33-47. [CrossRef]
  • 61. Sartor RB. Mechanisms of Disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390-407. [CrossRef]
  • 62. Amaro F, Chiarelli F. Growth and puberty in children with inflammatory bowel diseases. Biomedicines. 2020;8(11):458. [CrossRef]
  • 63. Yong Y, Fang B, Huang Y, et al. Tea tree oil Terpinen- 4-ol protects gut barrier integrity by upregulation of tight junction proteins via the ERK1/2-signaling pathway. Front Nutr. 2021;8:805612. [CrossRef]
  • 64. Głąbska D, Guzek D, Zakrzewska P, Włodarek D, Lech G. Lycopene, lutein and zeaxanthin may reduce faecal blood, mucus and pus but not abdominal pain in individuals with ulcerative colitis. Nutrients. 2016;8(10):613. [CrossRef]
  • 65. Cha JH, Kim WK, Ha AW, Kim MH, Chang MJ. Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr Res Pract. 2017;11(2):90-96. [CrossRef]
  • 66. Jiang LN, Liu YB, Li BH. Lycopene exerts antiinflammatory effect to inhibit prostate cancer progression. Asian J Androl. 2018;21(1):80-85. [CrossRef]
  • 67. Saedisomeolia A, Wood LG, Garg ML, Gibson PG, Wark PAB. Lycopene enrichment of cultured airway epithelial cells decreases the inflammation induced by rhinovirus infection and lipopolysaccharide. J Nutr Biochem. 2009;20(8):577-585. [CrossRef]
  • 68. Bae JW, Bae JS. Barrier protective effects of lycopene in human endothelial cells. Inflamm Res. 2011;60(8):751-758. [CrossRef]
  • 69. Bessler H, Salman H, Bergman M, Alcalay Y, Djaldetti M. In vitro effect of lycopene on cytokine production by human peripheral blood mononuclear cells. Immunol Investig. 2008;37(3):183- 190. [CrossRef]
  • 70. Hazlewood LC, Wood LG, Hansbro PM, Foster PS. Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma. J Nutr Biochem. 2011;22(1):95-100. [CrossRef]
  • 71. He Q, Zhou W, Xiong C, Tan G, Chen M. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway. Mol Med Rep. 2015;11(1):374-378. [CrossRef]
  • 72. El-Ashmawy NE, Khedr NF, El-Bahrawy HA, Hamada OB. Suppression of inducible nitric oxide synthase and tumor necrosis factor-alpha level by lycopene is comparable to methylprednisolone in acute pancreatitis. Dig Liver Dis. 2018;50(6):601-607. [CrossRef]
  • 73. Lv JC, Wang G, Pan SH, Bai XW, Sun B. Lycopene protects pancreatic acinar cells against severe acute pancreatitis by abating the oxidative stress through JNK pathway. Free Radic Res. 2015;49(2):151-163. [CrossRef]
APA Karaköy Z, CADIRCI E, Dincer B (2022). A New Target in Inflammatory Diseases: Lycopene. , 23 - 28. 10.5152/eurasianjmed.2022.22303
Chicago Karaköy Zeynep,CADIRCI ELIF,Dincer Busra A New Target in Inflammatory Diseases: Lycopene. (2022): 23 - 28. 10.5152/eurasianjmed.2022.22303
MLA Karaköy Zeynep,CADIRCI ELIF,Dincer Busra A New Target in Inflammatory Diseases: Lycopene. , 2022, ss.23 - 28. 10.5152/eurasianjmed.2022.22303
AMA Karaköy Z,CADIRCI E,Dincer B A New Target in Inflammatory Diseases: Lycopene. . 2022; 23 - 28. 10.5152/eurasianjmed.2022.22303
Vancouver Karaköy Z,CADIRCI E,Dincer B A New Target in Inflammatory Diseases: Lycopene. . 2022; 23 - 28. 10.5152/eurasianjmed.2022.22303
IEEE Karaköy Z,CADIRCI E,Dincer B "A New Target in Inflammatory Diseases: Lycopene." , ss.23 - 28, 2022. 10.5152/eurasianjmed.2022.22303
ISNAD Karaköy, Zeynep vd. "A New Target in Inflammatory Diseases: Lycopene". (2022), 23-28. https://doi.org/10.5152/eurasianjmed.2022.22303
APA Karaköy Z, CADIRCI E, Dincer B (2022). A New Target in Inflammatory Diseases: Lycopene. Eurasian Journal of Medicine, 54(1), 23 - 28. 10.5152/eurasianjmed.2022.22303
Chicago Karaköy Zeynep,CADIRCI ELIF,Dincer Busra A New Target in Inflammatory Diseases: Lycopene. Eurasian Journal of Medicine 54, no.1 (2022): 23 - 28. 10.5152/eurasianjmed.2022.22303
MLA Karaköy Zeynep,CADIRCI ELIF,Dincer Busra A New Target in Inflammatory Diseases: Lycopene. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.23 - 28. 10.5152/eurasianjmed.2022.22303
AMA Karaköy Z,CADIRCI E,Dincer B A New Target in Inflammatory Diseases: Lycopene. Eurasian Journal of Medicine. 2022; 54(1): 23 - 28. 10.5152/eurasianjmed.2022.22303
Vancouver Karaköy Z,CADIRCI E,Dincer B A New Target in Inflammatory Diseases: Lycopene. Eurasian Journal of Medicine. 2022; 54(1): 23 - 28. 10.5152/eurasianjmed.2022.22303
IEEE Karaköy Z,CADIRCI E,Dincer B "A New Target in Inflammatory Diseases: Lycopene." Eurasian Journal of Medicine, 54, ss.23 - 28, 2022. 10.5152/eurasianjmed.2022.22303
ISNAD Karaköy, Zeynep vd. "A New Target in Inflammatory Diseases: Lycopene". Eurasian Journal of Medicine 54/1 (2022), 23-28. https://doi.org/10.5152/eurasianjmed.2022.22303